{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:13:50Z","timestamp":1790644430041,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Liver cancer (LC) is a major concern in the Asia-Pacific region, particularly in China, Korea, and Japan. In this study, we aimed to investigate the burden, trends, and predictions related to LC in these countries.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using data from the Global Burden of Disease Study 2021, the epidemiological characteristics [incidence, deaths, and disability-adjusted life-years (DALYs)] for LC were analysed and stratified by specific etiologies in China, Japan, and South Korea. We examined temporal trends in LC burden over the last 32\u00a0years and projected changes over the following 25\u00a0years. The risk factors associated with LC deaths and DALYs were also investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In 2021, the highest LC-related incidence, mortality, and DALYs were recorded in China (196,637 incidents, 172,068 mortalities, and 4,890,023 DALYs), and the lowest in South Korea (18,642 incidents, 13,674 deaths, and 326,336 DALYs). South Korea recorded the highest age-standardized rates (ASRs) of incidence, mortality, and DALYs for LC (19.94 per 100,000, 14.53 per 100,000, and 354.57 per 100,000), and Japan the lowest (9.89, 7.29, and 145.74, respectively). From 1990 to 2021, LC incidents and deaths in the three countries increased, and the trends in ASRs decreased. LC incidents and deaths caused by five etiologies also increased in the past 32\u00a0years, and non-alcoholic steatohepatitis (NASH) was the largest increasing etiologies in China. Infections with hepatitis B virus remained the leading cause of LC in China and South Korea, while hepatitis C virus was the prevailing cause in Japan. High body mass index (BMI) was the most sharply increasing risk factor in China. Alcohol and drug use were the main risk factors for LC in South Korea and Japan, respectively. The LC burden in the three countries was projected to rise steadily between 2022 and 2046.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>LC remains a significant disease burden in China, Japan, and South Korea now and over the next 25\u00a0years. Regarding etiologies and risk factors, NASH and high BMI in China, alcohol use in South Korea, and drug use in Japan should receive significant attention.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s12072-024-10763-6","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T17:35:29Z","timestamp":1736616929000},"page":"441-459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Burden, trends, and predictions of liver cancer in China, Japan, and South Korea: analysis based on the Global Burden of Disease Study 2021"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7370-1831","authenticated-orcid":false,"given":"Si","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changcun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"issue":"3","key":"10763_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"27","key":"10763_CR2","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.3748\/wjg.14.4300","volume":"14","author":"AI Gomaa","year":"2008","unstructured":"Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol. 2008;14(27):4300\u20134308","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10763_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3350\/cmh.2022.0316","volume":"29","author":"S Choi","year":"2023","unstructured":"Choi S, Kim BK, Yon DK, Lee SW, Lee HG, Chang HH, et al. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990\u20132019: a DALY-based analysis of the Global Burden of Disease 2019 study. Clin Mol Hepatol. 2023;29(2):433\u2013452","journal-title":"Clin Mol Hepatol"},{"issue":"Suppl 1","key":"10763_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology (Baltimore, MD). 2021;73(Suppl 1):4\u201313","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"1","key":"10763_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3350\/cmh.2020.0176","volume":"27","author":"W Sohn","year":"2021","unstructured":"Sohn W, Lee HW, Lee S, Lim JH, Lee MW, Park CH, et al. Obesity and the risk of primary liver cancer: a systematic review and meta-analysis. Clin Mol Hepatol. 2021;27(1):157\u2013174","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"10763_CR6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ijc.34965","volume":"155","author":"NT Ho","year":"2024","unstructured":"Ho NT, Abe SK, Rahman MS, Islam R, Saito E, Gupta PC, et al. Diabetes is associated with increased liver cancer incidence and mortality in adults: a report from Asia Cohort Consortium. Int J Cancer. 2024;155(5):854\u2013870","journal-title":"Int J Cancer"},{"issue":"1","key":"10763_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/jgh.14005","volume":"33","author":"KP Ko","year":"2018","unstructured":"Ko KP, Shin A, Cho S, Park SK, Yoo KY. Environmental contributions to gastrointestinal and liver cancer in the Asia-Pacific region. J Gastroenterol Hepatol. 2018;33(1):111\u2013120","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10763_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","volume":"5","author":"SK Sarin","year":"2020","unstructured":"Sarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SMF, et al. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2020;5(2):167\u2013228","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10440","key":"10763_CR9","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","author":"AE Schumacher","year":"2024","unstructured":"Schumacher AE, Kyu HH, Aali A, Abbafati C, Abbas J, Abbasgholizadeh R, et al. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet (London, England). 2024;403(10440):1989\u20132056","journal-title":"Lancet (London, England)"},{"issue":"10258","key":"10763_CR10","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"CJ Murray","year":"2020","unstructured":"Murray CJ, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England). 2020;396(10258):1223\u20131249","journal-title":"Lancet (London, England)"},{"issue":"10258","key":"10763_CR11","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England). 2020;396(10258):1204\u20131222","journal-title":"Lancet (London, England)"},{"key":"10763_CR12","volume-title":"Standardization and decomposition of rates: a user\u2019s manual","author":"GP Das","year":"1993","unstructured":"Das GP. Standardization and decomposition of rates: a user\u2019s manual. Washington, DC: US Department of Commerce Economics and Statistics Administration; 1993"},{"key":"10763_CR13","doi-asserted-by":"publisher","first-page":"k2817","DOI":"10.1136\/bmj.k2817","volume":"362","author":"EB Tapper","year":"2018","unstructured":"Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999\u20132016: observational study. BMJ (Clin Res Ed). 2018;362:k2817","journal-title":"BMJ (Clin Res Ed)"},{"issue":"17","key":"10763_CR14","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1002\/sim.1481","volume":"22","author":"B M\u00f8ller","year":"2003","unstructured":"M\u00f8ller B, Fekjaer H, Hakulinen T, Sigvaldason H, Storm HH, Talb\u00e4ck M, et al. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med. 2003;22(17):2751\u20132766","journal-title":"Stat Med"},{"issue":"10","key":"10763_CR15","doi-asserted-by":"publisher","first-page":"e2440381","DOI":"10.1001\/jamanetworkopen.2024.40381","volume":"7","author":"M Li","year":"2024","unstructured":"Li M, Hu M, Jiang L, Pei J, Zhu C. Trends in cancer incidence and potential associated factors in China. JAMA Netw Open. 2024;7(10):e2440381","journal-title":"JAMA Netw Open"},{"issue":"19","key":"10763_CR16","doi-asserted-by":"publisher","first-page":"23416","DOI":"10.18632\/aging.203620","volume":"13","author":"RIR Macias","year":"2021","unstructured":"Macias RIR, Monte MJ, Serrano MA, Gonz\u00e1lez-Santiago JM, Mart\u00edn-Arribas I, Sim\u00e3o AL, et al. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics. Aging (Albany NY). 2021;13(19):23416\u201323434","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10763_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1440-1746.2009.05784.x","volume":"24","author":"MF Yuen","year":"2009","unstructured":"Yuen MF, Hou JL, Chutaputti A. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol. 2009;24(3):346\u2013353","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"10763_CR18","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","volume":"3","author":"T Akinyemiju","year":"2017","unstructured":"Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol. 2017;3(12):1683\u20131691","journal-title":"JAMA Oncol"},{"issue":"47","key":"10763_CR19","doi-asserted-by":"publisher","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","volume":"27","author":"X Liang","year":"2009","unstructured":"Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Epidemiological serosurvey of hepatitis B in China\u2014declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27(47):6550\u20136557","journal-title":"Vaccine"},{"issue":"3","key":"10763_CR20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3350\/cmh.2023.0110","volume":"29","author":"CH Lee","year":"2023","unstructured":"Lee CH, Choi GH, Choi HY, Han S, Jang ES, Chon YE, et al. Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: a nationwide study. Clin Mol Hepatol. 2023;29(3):779\u2013793","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"10763_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.35772\/ghm.2021.01078","volume":"3","author":"T Kanto","year":"2021","unstructured":"Kanto T. Messages from Japan policy for viral hepatitis. Glob Health Med. 2021;3(5):249\u2013252","journal-title":"Glob Health Med"},{"issue":"4","key":"10763_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/jvh.12828","volume":"25","author":"J Tanaka","year":"2018","unstructured":"Tanaka J, Akita T, Ohisa M, Sakamune K, Ko K, Uchida S, et al. Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011. J Viral Hepatitis. 2018;25(4):363\u2013372","journal-title":"J Viral Hepatitis"},{"issue":"7","key":"10763_CR23","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","volume":"34","author":"DQ Huang","year":"2022","unstructured":"Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 2022;34(7):969\u201377.e2","journal-title":"Cell Metab"},{"issue":"11","key":"10763_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10(11):686\u2013690","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"10763_CR25","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1007\/s00535-023-02040-4","volume":"58","author":"C Liu","year":"2023","unstructured":"Liu C, Zhu S, Zhang J, Wu P, Wang X, Du S, et al. Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis, 1990\u20132019: a decomposition and age-period-cohort analysis. J Gastroenterol. 2023;58(12):1222\u20131236","journal-title":"J Gastroenterol"},{"issue":"1","key":"10763_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(1):20\u201330","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"10763_CR27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S2213-8587(21)00118-2","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhao L, Gao L, Pan A, Xue H. Health policy and public health implications of obesity in China. Lancet Diabetes Endocrinol. 2021;9(7):446\u2013461","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10763_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3350\/cmh.2017.0079","volume":"24","author":"JY Jang","year":"2018","unstructured":"Jang JY, Kim DJ. Epidemiology of alcoholic liver disease in Korea. Clin Mol Hepatol. 2018;24(2):93\u201399","journal-title":"Clin Mol Hepatol"},{"key":"10763_CR29","volume-title":"Global status report on alcohol and health 2018","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Global status report on alcohol and health 2018. Geneva: World Health Organization; 2018"},{"issue":"1","key":"10763_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10147-014-0765-4","volume":"20","author":"T Matsuda","year":"2015","unstructured":"Matsuda T, Sobue T. Recent trends in population-based cancer registries in Japan: the Act on Promotion of Cancer Registries and drastic changes in the historical registry. Int J Clin Oncol. 2015;20(1):11\u201320","journal-title":"Int J Clin Oncol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10763-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-024-10763-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10763-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T05:36:08Z","timestamp":1744781768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-024-10763-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10763"],"URL":"https:\/\/doi.org\/10.1007\/s12072-024-10763-6","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,11]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}}]}}